| “Duration of deep molecular response” has most impact on the success of cessation of tyrosine kinase inhibitor treatment in chronic myeloid leukemia-results from the EURO-SKI trial S Saussele, J Richter, J Guilhot, H Hjorth-Hansen, AM de Almeida, ... Blood 130, 313, 2017 | 21 | 2017 |
| A potential role of fetal hemoglobin in the development of multidrug resistance A Fyrberg, K Skoglund, M Wolk, K Lotfi Biochemical and Biophysical Research Communications 427 (3), 456-460, 2012 | | 2012 |
| A prospective evaluation of patients' health-related quality of life during auto-SCT: a 3-year follow-up U Frödin, S Börjeson, J Lyth, K Lotfi Bone marrow transplantation 46 (10), 1345-1352, 2011 | 49 | 2011 |
| A randomized phase III study of venetoclax-based time-limited combination treatments (RVe, GVe, GIVe) vs standard chemoimmunotherapy (CIT: FCR/BR) in frontline chronic … B Eichhorst, C Niemann, AP Kater, M Fürstenau, J Von Tresckow, ... Blood 138, 71, 2021 | 49 | 2021 |
| ABCB1 SINGLE NUCLEOTIDE POLYMORPHISMS IN DE NOVO AML WITH NORMAL KARYOTYPE-IMPLICATIONS ON DRUG RESISTANCE AND SURVIVAL E Paul, K Lotfi, I Jakobsen Falk, R Rosenquist, C Paul, H Nahi, H Green | | 2009 |
| Abstract# 5451: Gene silencing of cytosolic 5, 3-dNT (cNT1) induces apoptosis in leukemic cells in response to purine and pyrimidine nucleoside analogues F Albertioni, S Mirzaee, A Wrabel, S Eriksson, K Lotfi Cancer Research 69 (9_Supplement), 5451-5451, 2009 | | 2009 |
| Activity profiles of 50-nucleotidases in peripheral blood cells from patients with untreated B-cell chronic lymphocytic leukemia: correlation to anti-cancer nucleoside … F Albertioni, N Bayat, K Karlsson, G Juliusson, C Peterson, S Eriksson, ... Proc. Am. Assoc. Cancer Res 46, 2005 | 2 | 2005 |
| Altered efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia cells expressing wild type or polymorphic ABCG2 K Skoglund, SB Moreno, K Lotfi, JI Jönsson, H Gréen Cancer Research 72 (8_Supplement), 5596-5596, 2012 | | 2012 |
| Altered expression of multidrug resistance (mDR1) gene in cells selected for resistance to 9-ß-D-Arabinofuranosylguanine K Lotfi, L Hjortsberg, C Peterson, F Albertioni | | 2012 |
| Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis MA Mosrati, K Willander, IJ Falk, M Hermanson, M Höglund, ... Oncotarget 6 (28), 25109, 2015 | 51 | 2015 |
| Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype H Green, IJ Falk, K Lotfi, E Paul, M Hermansson, R Rosenquist, C Paul, ... The pharmacogenomics journal 12 (2), 111-118, 2012 | 67 | 2012 |
| Association of TERT polymorphism with acute myeloid leukemia risk and prognosis K Lotfi, MA Mosrati, K Willander, I Jakobsen Falk, M Hermanson, ... Cancer Research 75 (15_Supplement), 5275-5275, 2015 | 2 | 2015 |
| Biochemical pharmacology and resistance to 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine, a novel analogue of cladribine in human leukemic cells K Lotfi, E Månsson, T Spasokoukotskaja, B Pettersson, J Liliemark, ... Clinical cancer research 5 (9), 2438-2444, 1999 | 117 | 1999 |
| Cell cycle dependent regulation of deoxycytidine kinase, deoxyguanosine kinase, and cytosolic 5′-nucleotidase I activity in MOLT-4 cells A Fyrberg, S Mirzaee, K Lotfi Nucleosides, Nucleotides and Nucleic Acids 25 (9-11), 1201-1204, 2006 | 4 | 2006 |
| Cell cycle effect on the activity of deoxynucleoside analogue metabolising enzymes A Fyrberg, F Albertioni, K Lotfi Biochemical and biophysical research communications 357 (4), 847-853, 2007 | 21 | 2007 |
| Clofarabine: factors influencing cytotoxicity and resistance in hematologic and solid malignancies X Wang, S Mirzaee, K Lotfi, S Eriksson, F Albertioni Cancer Research 70 (8_Supplement), 3654-3654, 2010 | | 2010 |
| Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells A Malyukova, D Ujvari, E Yektaei-Karin, A Zovko, HS Madapura, M Keszei, ... Cell Death & Disease 12 (10), 875, 2021 | 11 | 2021 |
| Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance K Lotfi, AL Zackrisson, C Peterson Cancer letters 178 (2), 141-149, 2002 | 75 | 2002 |
| CORRELATION BETWEEN CYTIDINE DEAMINASE SINGLE NUCLEOTIDE POLYMORPHISMS AND DNA METHYLATION IN ACUTE MYELOGENOUS LEUKEMIA in ANNALS OF ONCOLOGY, vol 23, issue, pp 14-14 IA Jakobsen Falk, KHZ Green, K Lotfi, A Fyrberg Oxford University Press (OUP): Policy A1 23, 14-14, 2012 | | 2012 |
| Correlation between cytidine deaminase single nucleotide polymorphisms and in vitro drug sensitivity, DNA methylation and outcome in normal karyotype acute … I Jakobsen Falk, A Fyrberg, M Hermanson, M Höglund, H Nahi, ... Cancer Research 73 (8_Supplement), 1170-1170, 2013 | | 2013 |
